144 results
DEFM14A
AGXRW
Agile Therapeutics Inc
25 Jul 24
Proxy related to merger
6:06am
with the Merger, (b) certain executive officers may receive severance payments and other benefits (described further below) pursuant … of the factors considered by the Board in reaching this decision, including potentially negative factors against which the anticipated benefits of the Merger
PREM14A
AGXRW
Agile Therapeutics Inc
12 Jul 24
Preliminary proxy related to merger
5:29pm
severance payments and other benefits (described further below) pursuant to their employment agreements with Agile or Agile’s change in control … negative factors against which the anticipated benefits of the Merger were weighed, and additional information on the recommendations of the Board, see
DEFA14A
AGXRW
Agile Therapeutics Inc
26 Jun 24
Additional proxy soliciting materials
8:15am
of, or provide economic benefits based, directly or indirectly, on the value or price of any capital stock or other voting securities of, or ownership … claims (other than routine claims for benefits), actions, suits, proceedings, investigations, litigations, inquiries, or other disputes by, on behalf
8-K
EX-10.1
AGXRW
Agile Therapeutics Inc
26 Jun 24
Entry into a Material Definitive Agreement
8:00am
and all such further instruments and documents and take such further action as Lender
may reasonably deem desirable (a) to obtain the full benefits … herein or therein. Borrower may not assign, transfer, hypothecate, delegate or otherwise convey
its rights, benefits, obligations or duties hereunder
8-K
EX-2.1
6geq2m
26 Jun 24
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.2
fhe8q
26 Jun 24
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
81b05g3fvgu5jxz5fay
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K/A
0cn4r7q wc7u8lxas
22 Aug 23
Departure of Directors or Certain Officers
8:30am